Company: HCTI
Filing Date: 2025-05-15
Form Type: 424B4
Source: 0001213900-25-044095
Chunk: 3

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-15
Form: 424B4
Chunk 3
---
 expenses and fees in connection with the
registration of the shares of Common Stock. The selling stockholders will bear all commissions and discounts, if any, attributable to
their sales of the shares of Common Stock.

Our Common Stock is listed on the Nasdaq Capital Market
LLC (“Nasdaq”) under the symbol “HCTI”. On March 31, 2025, the closing sale price of our Common Stock as reported
on Nasdaq was $0.2996. The number of shares of our Common Stock outstanding as of May 14, 2025 was 16,038,376.

Investment in our Common Stock involves risk. See “Risk Factors” contained in this prospectus, in our periodic reports filed from time to time with the Securities and Exchange Commission, which are incorporated by reference in this prospectus and in any applicable prospectus supplement. You should carefully read this prospectus and the documents we incorporate by reference, before you invest in our Common Stock.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is May 14, 2025

Table of Contents</div>

| ABOUT THIS PROSPECTUS                             |     |  ii |
| MARKET DATA                                       |     | iii |
| PROSPECTUS SUMMARY                                |     |   1 |
| RISK FACTORS                                      |     |   5 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS |     |   8 |
| USE OF PROCEEDS                                   |     |   9 |
| DIVIDEND POLICY                                   |     |   9 |
| SELLING STOCKHOLDERS                              |     |  12 |
| PLAN OF DISTRIBUTION                              |     |  15 |
| LEGAL MATTERS                                     |     |  17 |
| EXPERTS                                           |     |  17 |
| WHERE YOU CAN FIND MORE INFORMATION               |     |  17 |

Please read this prospectus
carefully. It describes our business, our financial condition and our results of operations. We have prepared this prospectus so that
you will have the information necessary to make an informed investment decision. You should rely only on the information contained in
this prospectus or to which we have referred you. No one has been authorized any person to provide you